Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 068 609.5 |
96 | EP file number | EAKZ | 14 77 1729.2 |
86 | WO file number | WAKZ | PCT/US2014/054960 |
97 | EP publication number | EPN | 3044231 |
87 | WO publication number | WPN | 2015038625 |
54 | Designation/title | TI | VEKTOREN DES ADENOASSOZIIERTEN VIRUS ENTHALTEND EIN FAKTOR-VIII GEN |
51 | IPC main class | ICM (ICMV) | C07K 14/755 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 48/00 (2006.01), C12N 15/86 (2006.01) |
22 | DE application date | DAT | Sep 10, 2014 |
96 | EP application date | EAT | Sep 10, 2014 |
86 | WO application date | WAT | Sep 10, 2014 |
43 | Date of first publication | OT | Mar 19, 2015 |
| Date of publication of grant | PET | Aug 5, 2020 |
71/73 | Applicant/owner | INH | BioMarin Pharmaceutical Inc., Novato, CA, US; St. Jude Children's Research Hospital, Memphis, TN, US; University College London, London, GB |
72 | Inventor | IN | COLOSI, Peter Cameron, San Anselmo, CA 94960, US; NATHWANI, Amit, London, WC1E 6HX, GB; MCINTOSH, Jenny, London, WC1E 6HX, GB; TUDDENHAM, Edward, London, WC1E 6HX, GB; Davidoff, Andrew, Memphis, TN, US |
74 | Representative | VTR | WSL Patentanwälte Partnerschaft mbB, 65185 Wiesbaden, DE |
| Address for service | | WSL Patentanwälte Partnerschaft mbB, 65185 Wiesbaden, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361877042 P Sep 12, 2013
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2023 000 013.0 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003044231 Searchable text:
EP000003044231 Original document:
EP000003044231B1 Searchable text:
EP000003044231B1 Original document:
WO002015038625 Searchable text:
WO002015038625 |
43 | Date of first publication | EVT | Mar 19, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Sep 2, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 28, 2024 (Show all update days)(Hide all update days)- Aug 28, 2024
- Due date: changed
- Procedures: Procedure relating to PCT application, Publication of PCT application, 19.03.2015: deleted
- Apr 5, 2024; Sep 6, 2023; Jul 27, 2023; Jun 22, 2023; Mar 14, 2023; Aug 27, 2022; Jul 7, 2022; Oct 6, 2021; Aug 21, 2021; Aug 12, 2021; Aug 10, 2021; Jul 28, 2021; Jul 9, 2021; Jun 3, 2021; May 16, 2021; Oct 8, 2020; Aug 20, 2020; Jul 16, 2020; Jan 30, 2020; Jun 28, 2018
- Historical data not available for this/these date(s)
- Sep 2, 2016
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 8, 2021 |
| Issue number | HN | 33 |
| Year | PJ | 2021 |
| Publication date | VT | Aug 19, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | BioMarin Pharmaceutical, Inc., Novato, Calif., US; St. Jude Children's Research Hospital, Memphis, Tenn., US; University College London, London, GB |
71/73 | Previous applicant/owner | INHF | BioMarin Pharmaceutical, Inc., Novato, Calif., US, University College London, London, GB |
| Date of update of the procedure | REGT | Jul 28, 2021 |
View procedures New applicant/owner details (No.: 12)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 21, 2023 |
| Issue number | HN | 30 |
| Year | PJ | 2023 |
| Publication date | VT | Jul 27, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | BioMarin Pharmaceutical Inc., Novato, CA, US; St. Jude Children's Research Hospital, Memphis, TN, US; University College London, London, GB |
71/73 | Previous applicant/owner | INHF | BioMarin Pharmaceutical, Inc., Novato, Calif., US, St. Jude Children's Research Hospital, Memphis, Tenn., US, University College London, London, GB |
| Date of update of the procedure | REGT | Jul 27, 2023 |